Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

Heba OmarW El AkelT ElbazMohamed El KassasK ElsaeedH El ShazlyM SaidM YousifA A GomaaA NasrM AbdAllahM KoranyS A IsmailM K ShakerW DossG EsmatImam WakedY El Shazly

Published in: Alimentary pharmacology & therapeutics (2017)

Real-world experience of generic SOF-DCV in patients with chronic HCV-G4 proved to be safe and associated with a high SVR12 rate, in patients with different stages of fibrosis.

Keyphrases

hepatitis c virus
end stage renal disease
newly diagnosed
human immunodeficiency virus
peritoneal dialysis
combination therapy
hepatitis c virus infection
patient reported outcomes